홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

Grepafloxacin

HCID 72474
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
119914-60-2
표준 SMILES
Cc1c(F)c(N2CCNC(C)C2)cc2c1c(=O)c(C(=O)O)cn2C1CC1
InChIKey
AIJTTZAVMXIJGM-UHFFFAOYSA-N
분자식
C19H22FN3O3
평균 분자량
359.4 g/mol
단동위원소 질량
359.16451973

개요

Grepafloxacin is a member of quinolines, a quinolone antibiotic and a fluoroquinolone antibiotic.

이름 및 식별자

우선 이름
Grepafloxacin
IUPAC
1-cyclopropyl-6-fluoro-5-methyl-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid
영어명
Grepafloxacin
분자식
C19H22FN3O3
분자량
359.39

이름 및 동의어

Grepafloxacin119914-60-21-cyclopropyl-6-fluoro-5-methyl-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acidGrepafloxacineGrepafloxacino1-cyclopropyl-6-fluoro-5-methyl-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acidL1M1U2HC313-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-OPC-17116DTXSID2048321grepafloxacinumRefChem:922501
이름 더 보기
dl-GrepafloxacinGrepafloxacin USP/EP/BPGrepafloxacin/OPC-17116/dl-Grepafloxacin1-Cyclopropyl-6-fluoro-7-(3-methyl-1-piperazinyl)-5-methyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid
DTXCID0028296J01MA11(+--)-1-cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid(RS)-1-cyclopropyl-6-fluoro-5-methyl-7-(3-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic acid631-454-3Raxar146863-02-7dl-Grepafloxacin Hydrochloride

데이터베이스 식별자

CAS
119914-60-2
PubChem CID
72474
DTXSID
DTXSID2048321
ChEMBL
CHEMBL583
ChEBI
CHEBI:5543
UNII
L1M1U2HC31
EC Number
631-454-3
Nikkaji
J384.494C

물성

구조 계산 물성

XLogP
-0.2
극성 표면적
72.9 Ų
수소 결합 공여자 수
2
수소 결합 수용자 수
7
회전 가능 결합 수
3
무거운 원자 수
26
형식 전하
0
복잡도
636

실험 및 물리화학적 성질

Drugs · 2건

Pharmaceuticals -> Anti infectives for systemic use -> Antibacterials for systemic use

Pharmaceuticals -> Antibiotics

LogP2.9
Solubility6.32e-01 g/L
Human DrugsPharmaceuticals
Physical DescriptionSolid

물리화학적 성질

녹는점
189 · 189-192 ºC
끓는 점
610 · 610.0±55.0 °C(Predicted)
밀도
1.366 · 1.366
저장 조건
2 · under inert gas (nitrogen or Argon) at 2–8 °C
용해도
DMSO(약간 용해됨), 메탄올(약간 용해됨)
물리적 상태
고체
산도 계수 (pKa)
6.44 · 6.44±0.50(Predicted)
색상
옅은 베이지부터 옅은 노란색까지
안정성
흡습성

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 4건

Danger

H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]

P264, P270, P301+P316, P321, P330, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 38 reports by companies from 1 notifications to the ECHA C&L Inventory.

유해성 정보

Hazard Classes and CategoriesAcute Tox. 3 (100%)

안전 데이터

신호 어
Danger
유해·위험 문구
암호 유해·위험 문구 위험 등급 범주 신호 어 그림 문자 P- 코드 H301

화학 및 산업

약리 정보

ATC Code · 2건

J - Antiinfectives for systemic use

QJ - Antiinfectives for systemic use

Protein Binding50%
PharmacodynamicsGrepafloxacin has in vitro activity against a wide range of gram-positive and gram-negative aerobic microorganisms, as well as some atypical microorganisms.
Mechanism of ActionGrepafloxacin exerts its antibacterial activity by inhibiting bacterial topoisomerase II (DNA gyrase) and topoisomerase IV, essential enzymes for duplication, transcription, and repair of bacterial DNA.
Biological Half-Life15 ± 3 hours
Metabolism/Metabolites · 1건

Primarily hepatic via CYP1A2 and CYP3A4. The major metabolite is a glucuronide conjugate; minor metabolites include sulfate conjugates and oxidative metabolites. The oxidative metabolites are formed mainly by the cytochrome P450 enzyme CYP1A2, while the cytochrome P450 enzyme CYP3A4 plays a minor role. The nonconjugated metabolites have little antimicrobial activity compared with the parent drug, and the conjugated metabolites have no antimicrobial activity

MeSH Pharmacological Classification · 2건

Substances that inhibit the growth or reproduction of BACTERIA.

Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II.

Absorption, Distribution and ExcretionRapidly and extensively absorbed following oral administration. The absolute bioavailability is approximately 70%.
Cellular LocationsCytoplasm

용도 및 제조

Use ClassificationPharmaceuticals

응용 분야

용도dl-Grepafloxacin is an antibacterial compound used to treat various respirator infections.

관련 반응

9건
반응 기록 만들기
HRID 805622 반응식
HRID 805622생성물로
HRID 948532 반응식
HRID 948532생성물로
HRID 1073758 반응식
HRID 1073758생성물로
HRID 1073759 반응식
HRID 1073759반응물로
HRID 1081423 반응식
HRID 1081423생성물로
HRID 1151607 반응식
HRID 1151607생성물로
HRID 2073845 반응식
HRID 2073845생성물로
HRID 2271276 반응식
HRID 2271276생성물로
이전1 / 2 페이지

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트